Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Int Assoc Provid AIDS Care. 2015 Oct 30;15(5):400–405. doi: 10.1177/2325957415614650

Table 2.

Clinical Characteristics for HIV Positive participants

HIV Positive (n=67)
(Mean ± SD or n (%)) HCV Negative
(n=21)
HCV Positive
(n=46)
P-Value
  CD4 absolute (1) 211 ± 166 257 ± 168 0.31
  Viral load (copies/ml) (1) 327,257 ± 284,442 71,417 ± 140,351 0.001
  Viral load suppressed (<400 Copies) (1) 0 (0%) 13 (29%) 0.007*
  HAART treatment (1) 3 (14%) 21 (47%) 0.01
    Efavirenz (1) 2 (10%) 8 (18%) 0.48*
    Nevirapine (1) 0 (0%) 3 (7%) 0.55*
    Ritonavir and/or Kaletra (1) 1 (5%) 9 (20%) 0.15*
*

Fisher’s Exact test used because 25% or more of cells had expected counts less than 5.0

1

HAART missing data for one participant. CD4 and Viral load missing data for three participants